Clinical Trial

A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor

Name: A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor — clinical trial record (NCT06245018)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This trial is to investigate the safety, efficacy of iNK in subjects with solid tumor. It is a dose escalation and extension trial.

Trial Details

NCT Number	NCT06245018
Lead Sponsor	Nuwacell Biotechnologies Co., Ltd.
Conditions	Solid Tumor
Enrollment	50 participants
Start Date	2024-02-01
Primary Completion	2027-03-01 (estimated)
Study Completion	2030-03-01 (estimated)
Updated on ClinicalTrials.gov	2024-02-07